2016
DOI: 10.1002/jhm.2664
|View full text |Cite
|
Sign up to set email alerts
|

Preventing hospital‐acquired venous thromboembolism: Improving patient safety with interdisciplinary teamwork, quality improvement analytics, and data transparency

Abstract: BACKGROUND: Hospital-acquired venous thromboembolism (HA-VTE) is a potentially preventable cause of morbidity and mortality. Despite high rates of venous thromboembolism (VTE) prophylaxis in accordance with an institutional guideline, VTE remains the most common hospital-acquired condition in our institution.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 6 publications
0
7
0
1
Order By: Relevance
“…The utilities of acute PE and DVT patients before and after prophylaxis education were 0.750(0.55-0.94) and 0.810(0.45-0.91), while the utility of non-VTE patients before and after prophylaxis education was 0.941 (0.75-1.00) [22][23] , and the upper and lower ranges were assumed as 20%. The probability of suspected VTE patients receiving/not receiving prophylaxis education was 0.096 and 0.150, respectively 24 . The costs were expressed as mean and the ranges were 95% confidence interval (CI).…”
Section: Discussionmentioning
confidence: 99%
“…The utilities of acute PE and DVT patients before and after prophylaxis education were 0.750(0.55-0.94) and 0.810(0.45-0.91), while the utility of non-VTE patients before and after prophylaxis education was 0.941 (0.75-1.00) [22][23] , and the upper and lower ranges were assumed as 20%. The probability of suspected VTE patients receiving/not receiving prophylaxis education was 0.096 and 0.150, respectively 24 . The costs were expressed as mean and the ranges were 95% confidence interval (CI).…”
Section: Discussionmentioning
confidence: 99%
“…12 To date, most data on the topic of VTE and pharmacoprophylaxis has been derived from the in-hospital stay. 12,22,23 Furthermore, most attempts to improve VTE prophylaxis have focused predominantly on in-hospital medication prescription. 24 To this point, publicly reported measures from the Centers for Medicare and Medicaid Services only assess whether a patient received at least 1 dose of VTE prophylaxis within the first day of hospitalization.…”
Section: Discussionmentioning
confidence: 99%
“…However, VTE prophylaxis can be cost effective, especially when compared to the alternative of no prophylaxis and the potential for DVT or PE occurrence. The Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project estimates that the inpatient costs of a single DVT or PE are $10,000 and $20,000, respectively [ 101 ]. Cain et al.…”
Section: Discussionmentioning
confidence: 99%